NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

2021996 citationsJournal Articlebronze Open Access

Authors

David S. Ettinger · Sidney Kimmel Comprehensive Cancer Center

Douglas E. Wood · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Dara L. Aisner · University of Colorado Cancer Center

Wallace Akerley · Huntsman Cancer Institute

Jessica R. Bauman · Fox Chase Cancer Center

Ankit Bharat · Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Topics & Keywords

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the National Comprehensive Cancer Network

Volume 19, Issue 3, pp. 254-266

DOI: 10.6004/jnccn.2021.0013

Field-Weighted Citation Impact: 137.53